Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients

European Journal of Cancer Prevention

Volumn 10, Issue 1, 2001, Pages 69-75

  Koriyama, C ^a,b,c,d   Shinkura, R ^a,b,c,d   Hamasaki, Y ^a,b,c,d   Fujiyoshi, T ^a,b,c,d   Eizuru, Y ^a,b,c,d   Tokunaga, M ^a,b,c,d  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kagoshima City Hospital   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d Kodama Hospital   (Japan)

Author keywords

EBV; HLA; Stomach neoplasms

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR2 ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; EPSTEIN BARR VIRUS; FEMALE; GENETIC MARKER; HLA TYPING; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; VIRUS DETECTION; VIRUS INFECTION;

EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; HLA ANTIGENS; HUMANS; IN SITU HYBRIDIZATION; JAPAN; MALE; STOMACH NEOPLASMS;

EID: 0035091774     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200102000-00008     Document Type: Article

References (22)

1. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells
2. Epstein-Barr virus: Summary of data reported and evaluation
3. Statistical analysis of molecular epidemiology studies employing case-series
4. HLA and nasopharyngeal carcinoma in Chinese. A further study
5. Description of and in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues
6. Epstein-Barr-virus-associated gastric cancer in Russia
7. Epstein-Barr virus-associated gastric carcinoma in Mexico: Analysis of 135 consecutive gastrectomies in two hospitals
8. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein
9. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups
10. Isolation of cytotoxic lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: Implications for viral persistence and tumor surveillance
11. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma
12. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region
13. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines
14. EB virus
15. Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: Association with clinico-pathologic factors and HLA-subtype
16. Epstein-Barr Virus
17. Epstein-Barr virus-associated gastric adenocarcinoma
18. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan
19. Microdroplet testing for HLA-A, -B, -C, and -D antigens
20. Epstein-Barr virus related gastric cancer in Japan: A molecular patho-epidemiological study
21. Adjusted P-values for simultaneous inference